Literature DB >> 4025948

Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients.

E Badui, D Garcia-Rubi, E Robles, J Jimenez, L Juan, M Deleze, A Diaz, G Mintz.   

Abstract

One hundred consecutive female patients with active systemic lupus erythematosus (SLE) were studied from the cardiovascular point of view by means of non invasive methods. Seventy percent of the cases presented some type of cardiovascular anomaly. Seventy four percent of the resting electrocardiograms were abnormal as well as 72% of the M mode echocardiograms and 55% of the cardiac X ray series. The most frequent observed complications were: pericarditis and or pericardial effusion (39%), arterial hypertension (22%), ischemic heart disease (16%), myocarditis (14%), congestive heart failure (10%), pulmonary hypertension (9%), valvular heart disease (9%), pleural effusion (7%) and cerebro vascular accident (3%). We analyzed each one of these complications and found of special interest the high incidence of ischemic heart disease which is more frequent than has been hitherto reported. Ischemic heart disease was observed in two types of patients: a) Those with long term steroid therapy. In these, the mechanism seems to be an atherosclerotic disease probably induced by the chronic use of steroids. The management of these cases do not differ from other types of coronary heart disease due to atherosclerosis. b) Those with frank episodes of vasculitis in whom the basic mechanism is an inflammatory process of the coronary arteries and its treatment is fundamentally that of the vasculitis. We consider necessary to study routinely all patients with SLE through non invasive cardiological methods.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025948     DOI: 10.1177/000331978503600705

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  30 in total

1.  [A wolf in sheep's clothing: atypical systemic lupus erythematosus (SLE) presenting as cardiovascular disease].

Authors:  Ingo H Tarner; Uwe Lange; Katharina Madlener; Katharina Classen; Reinhard Kandolf; Johannes Sperzel; Ulf Müller-Ladner
Journal:  Med Klin (Munich)       Date:  2010-04

2.  Premature myocardial infarction in a young woman with systemic lupus erythematosus.

Authors:  Nurşen Düzgün; Türkan Mete
Journal:  Rheumatol Int       Date:  2006-09-09       Impact factor: 2.631

Review 3.  Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions.

Authors:  Jürgen Braun; Klaus Krüger; Bernhard Manger; Matthias Schneider; Christof Specker; Hans Joachim Trappe
Journal:  Dtsch Arztebl Int       Date:  2017-03-24       Impact factor: 5.594

4.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

5.  Systemic lupus erythematosus complicated by dilated cardiomyopathy and severe heart failure.

Authors:  Celalettin Usalan; Hakan Buyukhatipoglu; Ozlem Tiryaki
Journal:  Clin Rheumatol       Date:  2005-12-14       Impact factor: 2.980

6.  Echocardiographic Assessment of Diastolic Function in Children with Incident Systemic Lupus Erythematosus.

Authors:  Joyce C Chang; Brian R White; Matthew D Elias; Rui Xiao; Andrea M Knight; Pamela F Weiss; Laura Mercer-Rosa
Journal:  Pediatr Cardiol       Date:  2019-04-30       Impact factor: 1.655

7.  Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.

Authors:  J C Chang; R Xiao; L Mercer-Rosa; A M Knight; P F Weiss
Journal:  Lupus       Date:  2018-10-14       Impact factor: 2.911

8.  Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

Authors:  Ayse Cefle; Murat Inanc; Mehmet Sayarlioglu; Sevil Kamali; Ahmet Gul; Lale Ocal; Orhan Aral; Meral Konice
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

9.  Short-term perioperative all-cause mortality and cardiovascular events in women with systemic lupus erythematosus.

Authors:  Ali Yazdanyar; Mary Chester Wasko; Lisabeth V Scalzi; Kevin L Kraemer; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-06       Impact factor: 4.794

10.  Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.

Authors:  Carlos Borelli Zeller; Simone Appenzeller
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.